-+ 0.00%
-+ 0.00%
-+ 0.00%
Pharming CEO Chouraqui steps down; names Marsh, Lynard interim co-CEOs
Share
Listen to the news
Pharming CEO Chouraqui steps down; names Marsh, Lynard interim co-CEOs
  • Pharming announced CEO and executive director Fabrice Chouraqui stepped down with immediate effect.
  • Chief Commercial Officer Leverne Marsh named interim co-CEO to run patient-focused operations.
  • Chief Financial Officer Kenneth Lynard named interim co-CEO to oversee global corporate functions.
  • Board launched a formal search for a permanent CEO successor.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pharming Group NV published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609290100OMX_____CNEWS_EN_GNW1001275065_en) on September 29, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending